Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 6227-6233, November 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, L.
Right arrow Articles by Clemmensen, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, L.
Right arrow Articles by Clemmensen, I.

Stromal Fibronectin Staining Pattern and Metastasizing Ability of Human Breast Carcinoma1

Lise Christensen2, Maja Nielsen, Johan Andersen and Inge Clemmensen

Department of Pathology, Rigshospitaler, University of Copenhagen [L. C.]; Department of Pathology, Frederiksberg and Glostrup County Hospital, Copenhagen [M. N.]; Department of Pathology, University Hospital of Odense, Odense [J. A.]; and Department of Clinical Microbiology and Immunology, Hvidovre Hospital, University of Copenhagen [I. C.]; Denmark

The peripheral stromal fibronectin (FN) staining patterns of invasive breast carcinomas (IBC) from 77 women were compared to the aggressivity of the tumors, which in each case had been determined through a complete clinical follow-up and autopsy investigation. Polyclonal, monospecific rabbit antibody to human FN was applied on formalin-fixed, paraffin-embedded tissue sections using the peroxidase-antiperoxidase staining technique. An FN-positive staining reaction was defined as a constant, diffuse, or pericellular demarcation of FN-positive fibers surrounding tumor cells at the invasive border. In lack of such a staining pattern, FN-negative staining was recorded. The FN-positive staining reaction was significantly associated with a low metastatic potential and appeared in a multivarians analysis to be an excellent prognostic factor, which surpassed other known parameters, such as clinical stage, histological type or grade, and lymph node status. 27 out of 31 women, who died without evidence of metastatic spread, had FN-positive IBC (87%) in contrast to women with metastatic disease, where only 15 out of 46 had FN-positive tumors (33%). An extensive histopathological examination of the contralateral breast revealed in this latter group a high rate of second primaries (22/46), which might have been responsible for the metastatic spread. If these women with bilateral IBC were excluded, only three metastasizing tumors with a FN-positive staining pattern remained, suggesting that the prognostic value of the FN-staining pattern along the invasive border of IBC might be even higher than anticipated from this study.

1 Supported by grants from the Educational Research Council of Greenland, The Faroe Islands and Greater Copenhagen, Denmark, the Danish Medical Research Council, Mrs. Astrid Thaysens Foundation, and the Danish Foundation for the Advancement of Medical Science.

2 To whom reprint requests should be addressed, at the Department of Pathology, Rigshospitalet, Frederik den V's vej 11, 2100 Copenhagen Ø., Denmark.

Received 1/11/88. Revised 6/14/88. Accepted 8/ 2/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. S. Rosman, S. Phukan, C.-C. Huang, and B. Pasche
TGFBR1*6A Enhances the Migration and Invasion of MCF-7 Breast Cancer Cells through RhoA Activation
Cancer Res., March 1, 2008; 68(5): 1319 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Sánchez-Carbayo, M. Urrutia, J. M. G. de Buitrago, and J. A. Navajo
Evaluation of Two New Urinary Tumor Markers: Bladder Tumor Fibronectin and Cytokeratin 18 for the Diagnosis of Bladder Cancer
Clin. Cancer Res., September 1, 2000; 6(9): 3585 - 3594.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1
J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.